Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

CNS 3

Conditions

Glioma 3Severe Combined Immunodeficiency 1Neuroblastoma 1Neoplasms 1Neoplasm Metastasis 1Mucopolysaccharidosis I 1Lung Neoplasms 1Hematologic Neoplasms 1Glioblastoma 1Astrocytoma 1Adenocarcinoma 1

Interventions

Temozolomide 109Magnetic Resonance Spectroscopy 52Bevacizumab 52Radiotherapy 44Irinotecan 27Blood Specimen Collection 19Surgical Procedures, Operative 16Radiation 15Aminolevulinic Acid 15Carboplatin 13fluorodopa F 18 12Nivolumab 12Radiotherapy, Intensity-Modulated 11Carmustine 11Radiosurgery 10Magnetic Resonance Imaging 10pembrolizumab 9Topotecan 9Specimen Handling 9Everolimus 9Erlotinib Hydrochloride 9Biopsy 9poly ICLC 8Surveys and Questionnaires 8Standard of Care 8Etoposide 8Drug Therapy 8Lomustine 7Filgrastim 7Cyclophosphamide 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Glioma × Cancer Vaccines × Clear all
NCT03879512 2024-09-19

Autologous Dendritic Cells, Metronomic Cyclophosphamide and Checkpoint Blockade in Children With Relapsed HGG

Wuerzburg University Hospital

Phase 1/2 Completed
24 enrolled
CNS

Astrocytoma, Glioma

NCT06156150 2023-12-05

The Role of B7-H4 in Tumor Vaccine

Huashan Hospital

Recruiting
160 enrolled
CNS

Glioma

NCT06102837 2023-10-26

Tumor Vaccines for Solid Tumors

Huashan Hospital

Recruiting
340 enrolled
CNS

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡